These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9217010)

  • 1. COS-1 cell expression and one-step affinity protein purification and activity of epitope-tagged human erythropoietin and of site-directed mutants.
    Bill RM; Flitsch SL; Bicknell R
    Biochim Biophys Acta; 1997 Jun; 1340(1):13-20. PubMed ID: 9217010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective in vitro glycosylation of recombinant proteins: semi-synthesis of novel homogeneous glycoforms of human erythropoietin.
    Macmillan D; Bill RM; Sage KA; Fern D; Flitsch SL
    Chem Biol; 2001 Feb; 8(2):133-45. PubMed ID: 11251288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and mutagenesis of recombinant human and murine erythropoietins in Escherichia coli.
    Bill RM; Winter PC; McHale CM; Hodges VM; Elder GE; Caley J; Flitsch SL; Bicknell R; Lappin TR
    Biochim Biophys Acta; 1995 Mar; 1261(1):35-43. PubMed ID: 7893759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of N-linked glycosylation on the function and expression of the human secretin receptor.
    Pang RT; Ng SS; Cheng CH; Holtmann MH; Miller LJ; Chow BK
    Endocrinology; 1999 Nov; 140(11):5102-11. PubMed ID: 10537138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural role of amino acids 99-110 in recombinant human erythropoietin.
    Chern YJ; Chung TW; Sytkowski AJ
    Eur J Biochem; 1991 Dec; 202(2):225-9. PubMed ID: 1761028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenesis of N-glycosylation sites in the human vasoactive intestinal peptide 1 receptor. Evidence that asparagine 58 or 69 is crucial for correct delivery of the receptor to plasma membrane.
    Couvineau A; Fabre C; Gaudin P; Maoret JJ; Laburthe M
    Biochemistry; 1996 Feb; 35(6):1745-52. PubMed ID: 8639654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-function relationships of the erythropoietin molecule.
    Lappin TR; Winter PC; Elder GE; McHale CM; Hodges VH; Bridges JM
    Ann N Y Acad Sci; 1994 Apr; 718():191-201; discussion 201-2. PubMed ID: 8185227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenesis disrupts posttranslational processing of the Na,K-ATPase catalytic subunit.
    Petrosian SA; Carr DL; Guerrero G; Pressley TA
    Arch Biochem Biophys; 1998 Sep; 357(2):249-58. PubMed ID: 9735165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific antibodies to human erythropoietin: immunoaffinity purification of urinary and recombinant hormone.
    Wojchowski DM; Sue JM; Sytkowski AJ
    Biochim Biophys Acta; 1987 Jun; 913(2):170-8. PubMed ID: 2439124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble expression and partial purification of recombinant human erythropoietin from E. coli.
    Jeong TH; Son YJ; Ryu HB; Koo BK; Jeong SM; Hoang P; Do BH; Song JA; Chong SH; Robinson RC; Choe H
    Protein Expr Purif; 2014 Mar; 95():211-8. PubMed ID: 24412408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of site-directed removal of N-glycosylation sites in human erythropoietin on its production and biological properties.
    Yamaguchi K; Akai K; Kawanishi G; Ueda M; Masuda S; Sasaki R
    J Biol Chem; 1991 Oct; 266(30):20434-9. PubMed ID: 1657925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of residues important in hormone binding to the extracellular domain of the luteinizing hormone/chorionic gonadotropin receptor by site-directed mutagenesis and modeling.
    Bhowmick N; Huang J; Puett D; Isaacs NW; Lapthorn AJ
    Mol Endocrinol; 1996 Sep; 10(9):1147-59. PubMed ID: 8885249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant Human Erythropoietin with Additional Processable Protein Domains: Purification of Protein Synthesized in Escherichia coli Heterologous Expression System.
    Grunina TM; Demidenko AV; Lyaschuk AM; Poponova MS; Galushkina ZM; Soboleva LA; Cherepushkin SA; Polyakov NB; Grumov DA; Solovyev AI; Zhukhovitsky VG; Boksha IS; Subbotina ME; Gromov AV; Lunin VG; Karyagina AS
    Biochemistry (Mosc); 2017 Nov; 82(11):1285-1294. PubMed ID: 29223155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and biological properties of erythropoietin in Xenopus laevis.
    Nogawa-Kosaka N; Hirose T; Kosaka N; Aizawa Y; Nagasawa K; Uehara N; Miyazaki H; Komatsu N; Kato T
    Exp Hematol; 2010 May; 38(5):363-72. PubMed ID: 20193733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-level expression and purification of a recombinant human erythropoietin produced using a baculovirus vector.
    Quelle FW; Caslake LF; Burkert RE; Wojchowski DM
    Blood; 1989 Aug; 74(2):652-7. PubMed ID: 2752139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretory production of erythropoietin and the extracellular domain of the erythropoietin receptor by Bacillus brevis: affinity purification and characterization.
    Nagao M; Inoue K; Moon SK; Masuda S; Takagi H; Udaka S; Sasaki R
    Biosci Biotechnol Biochem; 1997 Apr; 61(4):670-4. PubMed ID: 9145527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilizing the C-terminal cleavage activity of a protein splicing element to purify recombinant proteins in a single chromatographic step.
    Chong S; Montello GE; Zhang A; Cantor EJ; Liao W; Xu MQ; Benner J
    Nucleic Acids Res; 1998 Nov; 26(22):5109-15. PubMed ID: 9801307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affinity purification of erythropoietin from cell culture supernatant combined with MALDI-TOF-MS analysis of erythropoietin N-glycosylation.
    Falck D; Haberger M; Plomp R; Hook M; Bulau P; Wuhrer M; Reusch D
    Sci Rep; 2017 Jul; 7(1):5324. PubMed ID: 28706253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-glycosylation requirements for the AT1a angiotensin II receptor delivery to the plasma membrane.
    Deslauriers B; Ponce C; Lombard C; Larguier R; Bonnafous JC; Marie J
    Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):397-405. PubMed ID: 10191272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A point mutation in the MyoD basic domain imparts c-Myc-like properties.
    Van Antwerp ME; Chen DG; Chang C; Prochownik EV
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9010-4. PubMed ID: 1329087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.